MYC Promotes Bone Marrow Stem Cell Dysfunction in Fanconi Anemia
- 29 September 2020
- journal article
- research article
- Published by Elsevier in Cell Stem Cell
- Vol. 28 (1) , 33-47.e8
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01HL052725)
- National Institutes of Health (P01HL048546)
- Leukemia and Lymphoma Society (6237-13)
- Horizon 2020 (667403)
- Fanconi Cancer Foundation
- Research Council of Finland
This publication has 73 references indexed in Scilit:
- LSK Derived LSK– Cells Have a High Apoptotic Rate Related to Survival Regulation of Hematopoietic and Leukemic Stem CellsPLOS ONE, 2012
- Diagnosis of Fanconi Anemia: Chromosomal Breakage AnalysisAnemia, 2012
- Qualitative Network Modeling of the Myc-p53 Control System of Cell Proliferation and DifferentiationBiophysical Journal, 2011
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- Hematopoietic Stem Cell Defects in Mice with Deficiency of Fancd2 or Usp1Stem Cells, 2010
- Mouse models of Fanconi anemiaMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2009
- Hematopoietic Stem Cell Function and Survival Depend on c-Myc and N-Myc ActivityCell Stem Cell, 2008
- CXCR4 is required for the quiescence of primitive hematopoietic cellsJournal of Experimental Medicine, 2008
- Aberrant activation of stress-response pathways leads to TNF-α oversecretion in Fanconi anemiaBlood, 2008
- TNF-α induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cellsJournal of Clinical Investigation, 2007